Anti-Drug Antibody (ADA) Assays
At Celerion, we partner with you to understand the right approach for your ADA testing.
From traditional, 3-tiered testing strategies to single-tier screening assays and application of signal-to-noise and/or singlicate analysis, we offer a range of custom ADA approaches to ensure our solutions are appropriate for your program and consistent with your immunogenicity risk assessments.
Leverage our expertise for smoother, streamlined ADA method development.
Every ADA method has a unique set of targets for performance, from overcoming selectivity challenges to ensuring high levels of drug tolerance. That’s why we take an informed approach to development, routinely incorporating strategies such as:
- Acid Dissociation
- Affinity Capture Elution (ACE)
- Solid Phase Extraction with Acid Dissociation (SPEAD)
- Biotin-Drug Extraction and Acid Dissociation (BEAD)
- Bead Extraction with Heat Dissociation (BEHD)
- PEG Precipitation and Acid Dissociation (PandA)
For decades, Celerion’s scientific teams have supported ADA assay development, validation, and sample testing across a wide range of therapeutic modalities, species, and phases. Contact us today to speak with an expert about your immunogenicity testing needs.